XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Angi Inc.
IAC
Redeemable Noncontrolling Interests
Total IAC Shareholders' Equity
Total IAC Shareholders' Equity
Angi Inc.
Total IAC Shareholders' Equity
IAC
Common Stock
Common Stock, $0.0001 par value
Common Stock
Class B Common Stock, $0.0001 par value
Additional Paid-in Capital
Additional Paid-in Capital
Angi Inc.
Additional Paid-in Capital
IAC
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Angi Inc.
Treasury Stock
Treasury Stock
IAC
Noncontrolling Interests
Noncontrolling Interests
Angi Inc.
Balance at beginning of period at Dec. 31, 2021       $ 18,741                              
Increase (Decrease) in Temporary Equity [Roll Forward]                                      
Net (loss) earnings       (2,130)                              
Other comprehensive income (loss), net of income taxes       0                              
Purchase of noncontrolling interests       (1,179)                              
Adjustment of noncontrolling interests to redemption amount       24,229                              
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest and subsequent adjustment to liquidation value       (11,782)                              
Other       (644)                              
Balance at end of period at Dec. 31, 2022       27,235                              
Balance at beginning of period at Dec. 31, 2021 $ 7,748,960       $ 7,175,226     $ 8 $ 1 $ 6,265,669     $ 905,151 $ 4,397   $ 0   $ 573,734  
Balance at beginning of period (shares) at Dec. 31, 2021               83,922 5,789                    
Increase (Decrease) in Shareholders' Equity                                      
Net earnings (loss) (1,190,325)       (1,170,170)               (1,170,170)         (20,155)  
Other comprehensive income (loss), net of income taxes (18,776)       (17,541)                 (17,541)       (1,235)  
Stock-based compensation expense 126,699       70,808         70,808               55,891  
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (16,905) $ (8,627)     (16,905) $ (12,265)       (16,905) $ (12,276)       $ 11       $ 3,638
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (shares)               262                      
Purchase of treasury stock (85,300) (8,144) $ (85,323)     (8,144) $ (85,323)       (8,144) $ 0         $ (85,323)    
Adjustment of noncontrolling interests to redemption amount (24,229)       (24,229)         (24,229)                  
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest and subsequent adjustment to liquidation value 54,700       17,818         17,818               36,882  
Adjustment to noncontrolling interests resulting from the reorganization of a foreign subsidiary (255)       7,580         7,580               (7,835)  
Other (5,241)       (5,241)         (5,241)                  
Balance at end of period at Dec. 31, 2022 6,572,534       5,931,614     $ 8 $ 1 6,295,080     (265,019) (13,133)   (85,323)   640,920  
Balance at end of period (shares) at Dec. 31, 2022               84,184 5,789                    
Increase (Decrease) in Temporary Equity [Roll Forward]                                      
Net (loss) earnings       (1,175)                              
Adjustment of noncontrolling interests to redemption amount       7,567                              
Other       (249)                              
Balance at end of period at Dec. 31, 2023 33,378     33,378                              
Increase (Decrease) in Shareholders' Equity                                      
Net earnings (loss) 259,492       265,942               265,942         (6,450)  
Other comprehensive income (loss), net of income taxes 2,699       2,186                 2,186       513  
Stock-based compensation expense 121,950       73,562         73,562               48,388  
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (9,814) (6,288)     (9,814) (5,615)       (9,814) (5,620)       $ 5       (673)
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (shares)               281                      
Purchase of treasury stock (165,600) (11,099) $ (167,118)     (11,099) $ (167,118)       (11,099)           $ (167,118)    
Adjustment of noncontrolling interests to redemption amount (7,567)       (7,567)         (7,567)                  
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest and subsequent adjustment to liquidation value 0       5,527         5,527               (5,527)  
Other 214       243         243               29  
Balance at end of period at Dec. 31, 2023 6,755,003       6,077,861     $ 8 $ 1 6,340,312     923 (10,942)   (252,441)   677,142  
Balance at end of period (shares) at Dec. 31, 2023               84,465 5,789                    
Increase (Decrease) in Temporary Equity [Roll Forward]                                      
Net (loss) earnings       587                              
Adjustment of noncontrolling interests to redemption amount       (6,970)                              
Other       (1,580)                              
Balance at end of period at Dec. 31, 2024 25,415     $ 25,415                              
Increase (Decrease) in Shareholders' Equity                                      
Net earnings (loss) (533,917)       (539,897)               (539,897)         5,980  
Other comprehensive income (loss), net of income taxes (877)       (465)                 (465)       (412)  
Stock-based compensation expense 118,364       77,745         77,745               40,619  
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (14,845) (7,353)     (14,845) 4,024       (14,845) 4,013     11         $ (11,377)
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (shares)               366                      
Purchase of treasury stock   $ (28,581)       $ (28,581)         $ (28,581)                
Purchase of noncontrolling interests (16,019)       (11,296)         (11,296)               (4,723)  
Adjustment of noncontrolling interests to redemption amount 6,970       6,970         6,970                  
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest and subsequent adjustment to liquidation value 0       6,154         6,154               (6,154)  
Other 228       228         228                  
Balance at end of period at Dec. 31, 2024 $ 6,278,973       $ 5,577,898     $ 8 $ 1 $ 6,380,700     $ (538,974) $ (11,396)   $ (252,441)   $ 701,075  
Balance at end of period (shares) at Dec. 31, 2024               84,831 5,789